In recent years, scientists have shown that psilocybin mushrooms in small doses are excellent for the nervous system and can benefit the patient’s mental state. PTSD, ADHD, Clinical Depression, Seasonal Affective Disorder, Seizure Disorder, Borderline Disorder are just a few of the problems that magic therapy can deal with. But this has been proven much earlier.
A couple of years ago, microdosing mushrooms for migraines became an actively researched topic thanks to consumers’ reports, who suddenly stopped experiencing headaches.
After receiving numerous reviews, the Department of Neurology at Yale University became interested in the possibility of organizing a study of the effect of mushrooms on migraines. The head of the experiment was appointed Associate Professor Emmanuel A.D. Schindler.
According to him, they were not looking for a way to get rid of headaches using psilocybin for migraines but were trying to learn new details about the functioning of the human brain and how exactly neurological disorders affect it. In addition, confirming this theory would entail significant changes in neuropharmacology.
What was the study of the effects of magic mushrooms for migraines?
The scientists gathered a group of ten people, which included three men and seven women. They were all persistent and desperate patients with dreadful headaches. During the experiment, subjects took various capsules that could contain psilocybin or could contain a void. At the same time, none of the university staff, and even more so the participants in the experiment, did not have accurate information. Such measures were taken specifically to exclude the option of the placebo effect on the consciousness of patients.
Also, as a precautionary measure, patients were obliged to keep records of their pain sensations, all kinds of changes in their condition, and which pill, when, and what quantity they took.
And here’s the result – it turned out that it works and has nothing to do with placebo drugs.
It may sound surprising, but Schindler claims that participants in the experiment reported improvements when they took psilocybin microdoses. According to the records, the participants felt that the headache attacks were less severe and occurred less frequently due to the drug. At this stage, it is still not known in detail which psychedelic so positively influenced part of the brain. Still, most researchers, led by Schindler, believe that the matter is in the effect of psilocybin on serotonin receptors, which is why pain is dulled. Although this theory still needs to be proven, the findings are already a breakthrough!